• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

Triton's Meine Radiologie buys Diagnostikum Berlin
Triton's Meine Radiologie buys Diagnostikum Berlin

Acquisition of the radiology clinic chain is part of Meine Radiologie's buy-and-build strategy

  • Portfolio management
  • 07 October 2020
Investindustrial launches €600m China-Italy Fund
Investindustrial launches €600m China-Italy Fund

CIICF intends to support the expansion and development of Italian companies across the Chinese market

  • Funds
  • 05 October 2020
CDP Venture Capital leads €15m series-C for Wise
CDP Venture Capital leads €15m series-C for Wise

Indaco and Eureka also take part in the round, alongside previous backers including Principia and HTGF

  • Early-stage
  • 02 October 2020
Aksia's COC Farmaceutici buys Tubilux
Aksia's COC Farmaceutici buys Tubilux

With this acquisition the GP intends to create a platform for the development and manufacturing of ophthalmic products

  • Expansion
  • 01 October 2020
Eir Ventures leads seed funding round for Synklino
Eir Ventures leads seed funding round for Synklino

Startup focuses on developing therapies against viral infections

  • Early-stage
  • 30 September 2020
Soleus and Eir lead $64m series-D round for Galecto
Soleus and Eir lead $64m series-D round for Galecto

Biotech company has so far raised around $160m since being founded nine years ago

  • Expansion
  • 30 September 2020
CDPQ backs Colisée alongside EQT
CDPQ backs Colisée alongside EQT

EQT and CDPQ intend to support the company in its growth strategy in France and internationally

  • Buyouts
  • 28 September 2020
Phoenix-backed Sygnature acquires XenoGesis
Phoenix-backed Sygnature acquires XenoGesis

Previously, Sygnature has acquired two in-vivo pharmacology clinical research organisations

  • Portfolio management
  • 28 September 2020
Ampersand Capital Partners invests in GeneWerk
Ampersand Capital Partners invests in GeneWerk

Pharmaceuticals-focused GP aims to support GeneWerk's growth to meet demand for its services

  • Buyouts
  • 22 September 2020
Apax sells Neuraxpharm to Permira
Apax sells Neuraxpharm to Permira

Deal values the company at more than €1.6bn and is set to generate returns for Apax of 3.5x money

  • Exits
  • 22 September 2020
Morningside leads £40.6m series-B for Immune Regulation
Morningside leads £40.6m series-B for Immune Regulation

Morningside's Isaac Cheng will join the company's board of directors

  • Early-stage
  • 22 September 2020
PAI buys stake in Amplitude from Apax
PAI buys stake in Amplitude from Apax

Sale ends a nine-year holding period for Apax, which bought the business from Weinberg and Initiative & Finance

  • Buyouts
  • 21 September 2020
Novo, Sanofi lead $83m round for Lava Therapeutics
Novo, Sanofi lead $83m round for Lava Therapeutics

Corporate venture firms were joined by new and existing investors, including Gilde Healthcare

  • Expansion
  • 17 September 2020
Sagard NewGen backs Laboratoires Delbert
Sagard NewGen backs Laboratoires Delbert

Socadif Capital Investissement, Idia Capital Investissement and MACSF also invest in the company

  • Expansion
  • 15 September 2020
AMoon leads £23m series-A for Mina Therapeutics
AMoon leads £23m series-A for Mina Therapeutics

Gur Roshwalb, a managing director for AMoon, has joined the board of directors at Mina

  • Early-stage
  • 11 September 2020
Nord Holding buys Oton, Ohrwerk, creates AudiOsono
Nord Holding buys Oton, Ohrwerk, creates AudiOsono

GP plans to grow the hearing care buy-and-build platform to 150 sites in Germany via add-ons

  • Buyouts
  • 10 September 2020
Columbus Venture invests in €7.4m round for Algenex
Columbus Venture invests in €7.4m round for Algenex

Columbus deploys capital from Columbus Life Science Fund II, which targets early-stage biotech startups

  • Early-stage
  • 09 September 2020
GP Profile: ArchiMed
GP Profile: ArchiMed

Following the close of its new €1bn fund, ArchiMed's Denis Ribon discusses the firm's fundraising experience and investment pipeline

  • GPs
  • 07 September 2020
Heal Capital leads series-A for CereGate
Heal Capital leads series-A for CereGate

Existing investors High-Tech Gründerfonds (HTGF) and TruVenturo also take part in the round

  • Early-stage
  • 04 September 2020
Nord Holding acquires majority stake in HG Medical
Nord Holding acquires majority stake in HG Medical

Orthopaedic implants producer saw interest from a number of sponsors in a structured auction process

  • Buyouts
  • 04 September 2020
Mezzanine Management sells MBL to INVL
Mezzanine Management sells MBL to INVL

Seventh exit for Mezzanine Management's AMC funds in the last 12 months

  • Exits
  • 04 September 2020
Mandarin Capital buys Sidam
Mandarin Capital buys Sidam

GP intends to create a platform for new acquisitions across the biomedical sector in Italy

  • Buyouts
  • 03 September 2020
Claris Biotech I holds €30m first closing
Claris Biotech I holds €30m first closing

Fund targets early-stage rounds across the biopharmaceutical industry, focusing on oncology, immunology and rare diseases

  • Funds
  • 02 September 2020
Polaris acquires Swedish dental clinic chain Distrikstandvården
Polaris acquires Swedish dental clinic chain Distrikstandvården

Deal is the result of a sale auction, for which ABG Sundal Collier had been mandated last year

  • Expansion
  • 02 September 2020
242526
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013